MLH1 and urinary bladder carcinoma: Pathogenic mutations in these five genes were associated with moderate bladder cancer risk, with the crude OR ranging from 1.60 (95% CI: 0.88–2.91) for ATM to 4.88 (95% CI: 1.76–13.04) for MLH1.